IU researcher’s latest biotech startup raises $34.6M
Carmel-based MBX Biosciences Inc., co-founded by serial entrepreneur Richard DiMarchi, aims to develop therapeutics to treat rare endocrine disorders.
John Russell
Articles
East-side Indy nursing home tops statewide list of resident deaths from COVID-19
More than 43 long-term care facilities around the state have seen 10 residents or more die from the disease. State health officials released a breakdown by facility on Wednesday.
Lilly seeking $23.8M tax break to expand diabetes research, production
In the past seven years, the drugmaker has received tax breaks worth nearly $40 million in exchange for investing more than $500 million at its Indianapolis properties.
Hoosiers feeling anxious, depressed over COVID-19 pandemic
In direct response to the high levels of stress and anxiety due to the pandemic, Indiana officials on Monday launched a crisis hotline, which will allow Hoosiers to speak confidentially with a trained counselor at any hour free of charge.
New disease? No problem. Regenstrief has new codes to help sort through COVID-19
The codes are critical to help track the virus by allowing health systems and public health officials around the world seamlessly exchange information.
Wealthy hospitals get billions in federal bailout funds
Some are asking whether coronavirus aid funds are flowing to the neediest hospitals, or to those that already have deep financial resources, as the money is doled out to thousands of institutions nationwide.
Indiana sees number of COVID-19 cases climb, reversing weeks of downward trend
The increase is hitting more young people. People under 30 now account for 22% of all who have tested positive for COVID-19 in Indiana, up from 15% just a few weeks ago.
Indiana-based pharmacy business building $2.7M center in Plainfield
In Touch Pharmaceuticals serves long-term-care facilities in Illinois, Indiana and Michigan. It credits its system for helping clients reduce medication errors, cut waste and reduce costs.
Indiana regulators cut Duke Energy’s proposed rate hike by 60%
The Indiana Utility Regulatory Commission ruled Monday that Duke Energy, the state’s largest electricity provider, could collect an additional $146 million a year from customers. That’s down sharply from Duke Energy’s original request.
Indiana regulators rule utilities can’t charge consumers for lost revenue during pandemic
Monday’s ruling followed a huge uproar from ratepayers and elected officials, who widely criticized utilities for their request to charge customers for electricity they didn’t use when demand slowed down during health crisis lockdowns.
After years of turmoil, biotech testing firm aims to grow again
West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
Judge orders Lawson to produce documents on voting-machine security
Indiana Secretary of State Connie Lawson has argued that she shouldn’t have to turn over records about machine security because they could jeopardize cyberterrorism security. A judge wants to see for herself.
New Indiana COVID-19 cases dropping, in contrast to warm weather states
In Indiana, the number of new cases is trending down in recent weeks, even as thousands more Hoosiers get tested every day for the disease.
Indiana 100: Exec’s mission is to ‘transform information into knowledge’
Aarti Shah oversees Lilly’s global information technology, information security, advanced analytics and data sciences, and digital health.
Utilities face major pushback over pandemic-relief request
More than 2,300 people have complained by email to the Indiana Utility Consumer Counselor, which is on track to become the largest number of complaints for any single case in at least a decade.
Indiana’s No. 6 rank in pharmaceutical jobs could provide boost during recovery
The Hoosier state has 17,093 industry jobs spread out among 69 companies, from Indianapolis-based drugmaker Eli Lilly and Co. to startups scattered around the state, but mostly in clusters near research universities.
Lilly testing third potential treatment for COVID-19
The Indianapolis-based drugmaker said it is launching a global trial for the anti-inflammatory drug baricitinib, which it launched two years ago to treat moderately to severely active rheumatoid arthritis.
Lilly pledges $25M, 25,000 volunteer hours against injustice
The Lilly Foundation’s financial commitment over five years is aimed at finding solutions to racial inequity and social injustice primarily in Indianapolis, its surrounding counties and nationally.
Pandemic propels telemedicine’s growth into overdrive
Telemedicine is a $21 billion worldwide industry that has long promised to overhaul health care but struggled as recently as six months ago to get steady traction.
Lilly-funded partnership putting dent in diabetes in Indy neighborhoods
So far, the program has enrolled 275 people with diabetes. Health workers in the neighborhoods have completed more than 2,300 check-ins with them—helping them set up doctors’ visits, coaching them on how to shop for food, and helping them with dozens of related problems, from transportation needs to medical insurance.